132 related articles for article (PubMed ID: 31733110)
1. Use of antidepressants in women after prophylactic bilateral oophorectomy: A Danish national cohort study.
Abildgaard J; Ahlström MG; Nielsen DL; Daugaard G; Lindegaard B; Obel N; Lidegaard Ø
Psychooncology; 2020 Apr; 29(4):655-662. PubMed ID: 31733110
[TBL] [Abstract][Full Text] [Related]
2. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
[TBL] [Abstract][Full Text] [Related]
3. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
Armstrong K; Schwartz JS; Randall T; Rubin SC; Weber B
J Clin Oncol; 2004 Mar; 22(6):1045-54. PubMed ID: 14981106
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Rebbeck TR; Levin AM; Eisen A; Snyder C; Watson P; Cannon-Albright L; Isaacs C; Olopade O; Garber JE; Godwin AK; Daly MB; Narod SA; Neuhausen SL; Lynch HT; Weber BL
J Natl Cancer Inst; 1999 Sep; 91(17):1475-9. PubMed ID: 10469748
[TBL] [Abstract][Full Text] [Related]
6. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
8. Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.
Abildgaard J; Ahlström MG; Daugaard G; Nielsen DL; Pedersen AT; Lindegaard B; Obel N
JNCI Cancer Spectr; 2018 Jul; 2(3):pky034. PubMed ID: 31360861
[TBL] [Abstract][Full Text] [Related]
9. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer.
Meiser B; Tiller K; Gleeson MA; Andrews L; Robertson G; Tucker KM
Psychooncology; 2000; 9(6):496-503. PubMed ID: 11180584
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic oophorectomy in ovarian cancer prevention.
Kontoravdis A; Kalogirou D; Antoniou G; Kontoravdis N; Karakitsos P; Zourlas PA
Int J Gynaecol Obstet; 1996 Sep; 54(3):257-62. PubMed ID: 8889634
[TBL] [Abstract][Full Text] [Related]
11. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study.
Koch T; Jørgensen JT; Christensen J; Dehlendorff C; Priskorn L; Simonsen MK; Duun-Henriksen AK; Andersen ZJ; Juul A; Bräuner EV; Hickey M
Int J Cancer; 2021 Aug; 149(3):585-593. PubMed ID: 33729548
[TBL] [Abstract][Full Text] [Related]
14. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.
Piver MS; Jishi MF; Tsukada Y; Nava G
Cancer; 1993 May; 71(9):2751-5. PubMed ID: 8467455
[TBL] [Abstract][Full Text] [Related]
15. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.
Million Women Study Collaborators
BJOG; 2002 Dec; 109(12):1319-30. PubMed ID: 12504965
[TBL] [Abstract][Full Text] [Related]
16. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
17. Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?
Kotsopoulos J; Gronwald J; Lubinski J; McCuaig J; Lynch HT; Neuhausen SL; Foulkes WD; Weitzel JN; Senter L; Tung N; Eng C; Karlan B; Sun P; Narod SA;
Menopause; 2020 Feb; 27(2):156-161. PubMed ID: 31644510
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling.
Pocobelli G; Chubak J; Hanson N; Drescher C; Resta R; Urban N; Buist DS
Gynecol Oncol; 2012 Aug; 126(2):229-35. PubMed ID: 22564716
[TBL] [Abstract][Full Text] [Related]
19. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaecologists.
Jacobs I; Oram D
Br J Obstet Gynaecol; 1989 May; 96(5):510-5. PubMed ID: 2757978
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
